Los probióticos y su uso en el tratamiento de enfermedades

Probiotics and their use in the treatment of diseases.

Contenido principal del artículo

Daniela Corrales Benedetti
Janeth Arias Palacios

Resumen

Introducción: Los probióticos son microorganismos vivos que confieren beneficios a la salud del huésped, cuando se consumen en cantidades adecuadas, proporcionando una acción protectora contra patógenos y beneficios nutricionales. Su uso está asociado principalmente a alimentos funcionales o suplementos dietarios que contribuyen a un mejoramiento de la salud principalmente en humanos. Sin embargo, en los últimos años se han venido estudiando nuevos usos de estos, como son la prevención y alivio de ciertas enfermedades principalmente gastrointestinales. Así mismo los probióticos se han convertido en una alternativa para el tratamiento de enfermedades infecciosas, para mitigar el efecto negativo que los antibióticos pueden generar sobre el microbioma de los pacientes.

Objetivo: El objetivo de esta revisión bibliográfica fue identificar y compilar estudios e investigaciones en las cuales se evidencie el papel que juegan los probióticos en la solución de dichos problemas.

Métodos: Se realizó una revisión sistemática de artículos, de los cuales se seleccionaron aquellos que permitieron dar respuesta a los objetivos planteados.   

Resultados: Se logro identificar diferentes estudios donde se evidencio el beneficio del uso de los probióticos para el tratamiento de diferentes enfermedades. 

Conclusiones: Los probióticos son una novedosa alternativa en el tratamiento contra patógenos y en la prevención de algunas enfermedades en humanos. Ya que estos contribuyen en la reducción del agente causal de la enfermedad, reducción de los síntomas, inducción de la actividad inmune o disminución en el riesgo de contraer la infección.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

Daniela Corrales Benedetti, Pontificia Universidad Javeriana. Bogotá

Facultad de Ciencias, Programa de Microbiología, Pontificia Universidad Javeriana. Bogotá, Colombia

Janeth Arias Palacios, Pontificia Universidad Javeriana. Bogotá

Facultad de Ciencias, Programa de Microbiología, Pontificia Universidad Javeriana. Bogotá, Colombia

Palabras clave:

Referencias (VER)

1. FAO/WHO (Food and Agriculture Organization of the United Nations, World Health Organization). Probiotics in food. Health and nutritional properties and guidelines for evaluation. Food and agriculture organization of the United Nations and World Health Organization, Rome. FAO food and nutrition paper no. 85.2002

2. Oyetayo, V. O., & Oyetayo, F. L. Potential of probiotics as biotherapeutic agents targeting the innate immune system. African Journal of Biotechnology. 2005; 4, 123–127.

3. Shah, N. Functional cultures and health benefits. International Dairy Journal. 2007; 17(11), 1262-1277.

4. Kollath, W. Nutrition and the tooth system; general review with special referenceto vitamins. Deutsche zahnarztliche Zeitschrift.1953; 8, 7–16.

5. Hamilton-Miller, J., Gibson, G., & Bruck, W. Some insights into the derivation and early uses of the word ‘probiotic’. British Journal Of Nutrition. 2003; 90(04), 845.

6. Reid, G. Probiotics: definition, scope and mechanisms of action. Best Practice & Research Clinical Gastroenterology. 2016; 30(1), 17-25.

7. Hill, C., Guarner, F., Reid, G., Gibson, G., Merenstein, D., & Pot, B. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014; 11(8), 506-514.

8. Amara, A., & Shibl, A. Role of Probiotics in health improvement, infection control and disease treatment and management. Saudi Pharmaceutical Journal. 2015; 23(2), 107-114.

9. Fuller, R. Probiotics in man and animals. Journal of Applied Bacteriology. 1989 66,365– 378.

10. Oelschlaeger, Tobias A. 2010. "Mechanisms Of Probiotic Actions – A Review". International Journal Of Medical Microbiology. 2010; 300 (1), 57-62.

11. Wan, L. Y. M., Chen, Z. J., Shah, N. P., & El-Nezami, H. (2016). Modulation of intestinal epithelial defense responses by probiotic bacteria. Critical Reviews in Food Science and Nutrition. 2016;56, 2628–2641.

12. Balcázar, Josà Luis, Ignacio de Blas, Imanol Ruiz-Zarzuela, Daniel Vendrell, Olivia Gironés, and Josà Luis Muzquiz. "Enhancement Of The Immune Response And Protection Induced By Probiotic Lactic Acid Bacteria Against Furunculosis In Rainbow Trout (Oncorhynchus Mykiss)". FEMS Immunology & Medical Microbiology.2007; 51 (1): 185-193.

13. Cleusix, Valentine, Christophe Lacroix, Sabine Vollenweider, and Gwenaëlle Le Blay. "Glycerol Induces Reuterin Production And Decreases Escherichia Coli Population In An In Vitro Model Of Colonic Fermentation With Immobilized Human Feces". FEMS Microbiology Ecology. 2008; 63 (1): 56-64.

14. Dasari S, Anandan S, Rajendra W, Valluru L. Role of microbial flora in female genital tract: A comprehensive review. Asian Pacific Journal of Tropical Disease. 2016; 6(11): 909- 917.

15. Corr, S. C., Y. Li, C. U. Riedel, P. W. O'Toole, C. Hill, and C. G. M. Gahan. "Bacteriocin Production As A Mechanism For The Antiinfective Activity Of Lactobacillus Salivarius UCC118". Proceedings Of The National Academy Of Sciences.2007; 104 (18): 7617-7621.

16. Servin, Alain L. "Antagonistic Activities Of Lactobacilli And Bifidobacteria Against Microbial Pathogens". FEMS Microbiology Reviews. 2004; 28 (4): 405-440.

17. Alvarez-Olmos, M. I., and R. A. Oberhelman. "Probiotic Agents And Infectious Diseases: A Modern Perspective On A Traditional Therapy". Clinical Infectious Diseases.2001; 32 (11)

18. Asahara, T., K. Shimizu, K. Nomoto, T. Hamabata, A. Ozawa, and Y. Takeda. "Probiotic Bifidobacteria Protect Mice From Lethal Infection With Shiga Toxin-Producing Escherichia Coli O157:H7". Infection And Immunity. 2004; 72 (4): 2240-2247.

19. Chaucheyras-Durand, F., N.D. Walker, and A. Bach. "Effects Of Active Dry Yeasts On The Rumen Microbial Ecosystem: Past, Present And Future". Animal Feed Science And Technology. 2008;145 (1-4): 5-26.

20. Kim, Younghoon, Sejong oh, and Sae Hun Kim. "Released Exopolysaccharide (R-EPS) Produced From Probiotic Bacteria Reduce Biofilm Formation Of Enterohemorrhagic Escherichia Coli O157:H7". Biochemical And Biophysical Research Communications.2009; 379 (2): 324-329.

21. Liu, Zhengqi, Zhihong Zhang, Liang Qiu, Fen Zhang, Xiongpeng Xu, Hua Wei, and Xueying Tao. "Characterization And Bioactivities Of The Exopolysaccharide From A Probiotic Strain Of Lactobacillus Plantarum WLPL04". Journal Of Dairy Science. 2017;100 (9): 6895-6905.

22. La Ragione, R.M., A. Narbad, M.J. Gasson, and M.J. Woodward. "In Vivo Characterization Of Lactobacillus Johnsonii FI9785 For Use As A Defined Competitive Exclusion Agent Against Bacterial Pathogens In Poultry". Letters In Applied Microbiology.2004;38 (3): 197-205. doi:10.1111/j.1472-765x.2004.01474.x

23. Johnson-Henry, Kathene C., Karen E. Hagen, Mahsa Gordonpour, Thomas A. Tompkins, and Philip M. Sherman. "Surface-Layer Protein Extracts From Lactobacillus Helveticus Inhibit Enterohaemorrhagic Escherichia Coli O157:H7 Adhesion To Epithelial Cells". Cellular Microbiology.2007; 9 (2): 356-367.

24. UNAL TURHAN, Emel, Zerrin ERGINKAYA, Melek Hatice UNEY, and Emir Ayse OZER. "Listeria Monocytogenes’In Gelişimi Üzerine Probiyotik Biyofilmlerin İnaktivasyon Etkisi". Kafkas Universitesi Veteriner Fakultesi Dergisi. 2017.

25. Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46: 468–81.

26. George Kerry, R., Patra, J., Gouda, S., Park, Y., Shin, H., & Das, G. Benefaction of probiotics for human health: A review. Journal Of Food And Drug Analysis. 2018.

27. Scott, K., Antoine, J., Midtvedt, T., & van Hemert, S.. Manipulating the gut microbiota to maintain health and treat disease. Microbial Ecology In Health & Disease.2015; 26(0).

28. McFarland, L. From Yaks to Yogurt: The History, Development, and Current Use of Probiotics. Clinical Infectious Diseases.2015; 60(suppl 2), S85-S90.

29. Hayes, Shelby R., and Ashley J. Vargas. "Probiotics For The Prevention Of Pediatric Antibiotic-Associated Diarrhea”. 2018.

30. Szajewska, H., & Kołodziej, M. Systematic review with meta-analysis:Saccharomyces boulardiiin the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology & Therapeutics.2015; 42(7), 793-801.

31. Xie, C., Li, J., Wang, K., Li, Q., & Chen, D. Probiotics for the prevention of antibiotic- associated diarrhoea in older patients: A systematic review. Travel Medicine And Infectious Disease. 2015;13(2), 128-134.

32. Ojetti, V., Bruno, G., Ainora, M., Gigante, G., Rizzo, G., Roccarina, D., & Gasbarrini, A. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin- Based Second-Line Therapy. Gastroenterology Research And Practice, 2012, 1-6.

33. Dang, Y., Reinhardt, J., Zhou, X., & Zhang, G. The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis. Plos ONE.2014; 9(11), e111030.

34. Wang, Z., Chen, X., Zhang, Z., Li, Y., Deng, J., & Tu, J. et al. Effects of anti- Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans. Microbial Pathogenesis.2017: 109, 156-161.

35. Hauser G, Salkic N, Vukelic K, JajacKnez A, Stimac D. Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2015 May;94(17):e685.

36. Feng, J., Wang, F., Qiu, X., McFarland, L., Chen, P., & Zhou, R. et al. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis. European Journal Of Clinical Pharmacology,.2017;73(10), 1199-1208.

37. Friedman, G. The Role of Probiotics in the Prevention and Treatment of Antibiotic- Associated Diarrhea and Clostridium Difficile Colitis. Gastroenterology Clinics Of North America.2012; 41(4), 763-779.

38. Johnson, S., Maziade, P., McFarland, L., Trick, W., Donskey, C., & Currie, B. et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics?. International Journal Of Infectious Diseases.2012; 16(11), e786-e792.

39. Principi, N., Cozzali, R., Farinelli, E., Brusaferro, A., & Esposito, S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal Of Infection.2018; 76(2), 111-120.

40. Cao Y, Shen J, Ran ZH. Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Gastroenterol Res Pract.2014;872725.

41. Ford, A., Quigley, E., Lacy, B., Lembo, A., Saito, Y., & Schiller, L. et al. Efficacy of Prebiotics, Probiotics and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis. The American Journal Of Gastroenterology.2014; 109(10), 1547-1561.

42. EFSA Panel on Dietetic Products N and A (NDA). Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143,2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2010 Oct 1;8(10): n/a-n/a.

43. Patel, R., & Underwood, M. Probiotics and necrotizing enterocolitis. Seminars In Pediatric Surgery.2018; 27(1), 39-46.

44. Underwood, M. Impact of probiotics on necrotizing enterocolitis. Seminars In Perinatology.2017;41(1), 41-51.

45. Cancelo Hidalgo, M., Neyro Bilbao, J., & Baquero Úbeda, J. Tratamiento adyuvante de la vaginitis con probióticos. Grado de acuerdo basado en el método Delphi. Progresos De Obstetricia Y Ginecología.2014; 57(1), 4-13.

46. Rouxinol-Dias, A., Pinto, A., Janeiro, C., Rodrigues, D., Moreira, M., Dias, J., & Pereira,

47. P. Probiotics for the control of obesity – Its effect on weight change. Porto Biomedical Journal.2016;1(1), 12-24.

48. Chamberlain, R., & Lau, C. Probiotics are effective at preventing Clostridium difficile- associated diarrhea: a systematic review and meta-analysis. International Journal Of General Medicine.2016; 27.

49. Patel, R., & Underwood, M. Probiotics and necrotizing enterocolitis. Seminars In Pediatric Surgery.2018; 27(1), 39-46.

50. Minelli, E., & Benini, A. Relationship between number of bacteria and their probiotic effects. Microbial Ecology In Health & Disease.2008; 20(4)